OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Blood Circulating Non-Coding RNAs for the Clinical Management of Triple-Negative Breast Cancer
Tomasz Powrózek, Michael Ochieng Otieno
Cancers (2022) Vol. 14, Iss. 3, pp. 803-803
Open Access | Times Cited: 8

Showing 8 citing articles:

Predictive biomarkers for personalized medicine in breast cancer
Sylvie Rodrigues-Ferreira, Clara Nahmias
Cancer Letters (2022) Vol. 545, pp. 215828-215828
Open Access | Times Cited: 32

Prognostic and diagnostic values of non-coding RNAs as biomarkers for breast cancer: An umbrella review and pan-cancer analysis
Afshin Bahramy, Narges Zafari, Fatemeh Rajabi, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 12

Potential utility of miRNAs for liquid biopsy in breast cancer
Xiangrong Liu, Dimitri Papukashvili, Zhixiang Wang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 17

Extracellular vesicles-associated miRNAs in triple-negative breast cancer: from tumor biology to clinical relevance
Fernanda Costa Brandão Berti, Maria Vitoria Tofolo, Emanuelle Nunes-Souza, et al.
Life Sciences (2023) Vol. 336, pp. 122332-122332
Closed Access | Times Cited: 9

Gastric juice non-coding RNAs as potential biomarkers for gastric cancer
Ilgiz Gareev, Aamir Ahmad, Jiaqi Wang, et al.
Frontiers in Physiology (2023) Vol. 14
Open Access | Times Cited: 7

Insights into multidrug resistance mechanisms: Exploring distinct miRNAs as prospective therapeutic agents in triple negative breast cancer
Sercan Kenanoğlu, Hilal Akalın, Dicle Aslan, et al.
Gene Reports (2024) Vol. 37, pp. 102020-102020
Closed Access

Page 1

Scroll to top